Literature DB >> 187726

Comparison of the activities in inhibition of haemagglutination by different togaviruses for human serum lipoproteins and their constituents.

K F Shortridge, W K Ho.   

Abstract

The 3 major lipoprotein fractions of human serum were investigated for their ability to inhibit the haemagglutination of 24 different togaviruses including rubella virus and arboviruses from 5 antigenic groups. All viruses were inhibited by the 3 fractions and this was most evident with low and very low density lipoproteins; inhibitory activity appeared to be associated with the lipid part of the lipoproteins. When artificial dispersions of the lipids cholesterol, cholesteryl ester and triglyceride were emulsified with egg lecithin three categories of inhibitory activity were observed which were independent of virus antigenic grouping -- category 1, no activity; category 2, activity confined to cholesterol and category 3, activity for cholesterol and to a lesser extent the other lipids.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 187726     DOI: 10.1099/0022-1317-33-3-523

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Identification of lipid components of human serum lipoproteins involved in the inhibition of Sindbis virus infectivity, hemagglutination, and hemolysis.

Authors:  P Mastromarino; C Conti; S Rieti; N Orsi
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Colostrum as a source of togavirus inhibitors.

Authors:  K F Shortridge
Journal:  Arch Dis Child       Date:  1977-02       Impact factor: 3.791

3.  Relationship between enzymatic modifications of serum low density lipoproteins and their haemagglutination inhibiting activity towards Sindbis virus.

Authors:  P Mastromarino; L Seganti; N Orsi
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

4.  Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses.

Authors:  K F Shortridge
Journal:  J Clin Pathol       Date:  1977-05       Impact factor: 3.411

5.  Binding sites for rubella virus on erythrocyte membrane.

Authors:  P Mastromarino; S Rieti; L Cioè; N Orsi
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

6.  Use of sodium polyanetholesulfonate-CaCl2 for removal of serum nonspecific inhibitors of rubella hemagglutination: comparison with other polyanion-divalent cation combinations.

Authors:  M L Ellins; J B Campbell
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

7.  Rubella serology: a comparison of four methods for exclusion of non-specific serum inhibitors.

Authors:  T Traavik; O Spanne; S Mennen
Journal:  J Hyg (Lond)       Date:  1981-06

Review 8.  Innate defences against viraemia.

Authors:  I P Singh; S Baron
Journal:  Rev Med Virol       Date:  2000 Nov-Dec       Impact factor: 6.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.